Browsing Tag
cell therapy
19 posts
PHC Holdings signs exclusive deal to distribute MaxCyte ExPERT platform in Japan to advance non-viral cell engineering in CGT development
PHC Holdings signs exclusive deal to distribute MaxCyte’s ExPERT platform in Japan, expanding CGT manufacturing with scalable non-viral cell engineering
July 3, 2025
Portal Biotechnologies awarded $8m DARPA contract to create portable red blood cell therapy system for rapid field-based treatment
Portal Biotechnologies secures $8M DARPA contract to build a field-deployable red blood cell therapy device using mechanoporation technology.
June 24, 2025
Stem cell-based diabetes therapies at ADA 2025 show promise in eliminating insulin use for type 1 patients
VX-880 and immune-shielded stem cell islets show strong promise in clinical trials at ADA 2025, offering new possibilities in type 1 diabetes treatment.
June 22, 2025
AstraZeneca moves deeper into cell therapy with $1bn EsoBiotec acquisition
AstraZeneca’s $1 billion acquisition of EsoBiotec signals a major shift in cell therapy innovation. Find out how this deal could transform cancer treatment.
March 24, 2025
NLS Pharmaceutics advances Kadimastem merger with fundraising milestone
NLS Pharmaceutics Ltd., a Swiss biopharmaceutical company focused on therapies for rare central nervous system disorders, and Kadimastem…
January 8, 2025
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute…
October 7, 2024
Johnson & Johnson’s CARVYKTI achieves significant milestone in multiple myeloma treatment
Johnson & Johnson (NYSE: JNJ) has recently announced encouraging outcomes from the second interim analysis of the Phase…
July 7, 2024
Gamma Biosciences to sell Mirus Bio to Merck KGaA for $600m in key biotech deal
Merck KGaA, Darmstadt, Germany (XTRA:MRK), a leading global science and technology company, has agreed to acquire Mirus Bio…
May 26, 2024
Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings
Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for…
January 8, 2018